Evaluating the use of nasogastric tubes for small bowel obstruction treatment
The Utility of Treatment With Nasogastric Tube Placement for Small Bowel Obstruction in Adult Patients in the Emergency Department; an Observational Multicenter Study
University Hospital, Linkoeping · NCT06262815
This study is testing if using a nasogastric tube can help relieve pain and improve outcomes for adults with small bowel obstruction.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Linkoeping (other) |
| Locations | 8 sites (Göteborg and 7 other locations) |
| Trial ID | NCT06262815 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effectiveness of nasogastric tube placement in patients diagnosed with small bowel obstruction (SBO). It aims to assess the utility of this treatment approach, which has been a standard practice since the 1930s, in alleviating pain and improving patient outcomes. The study will include patients aged 18 and older who have been diagnosed with SBO, while excluding those who have undergone abdominal surgery recently or cannot provide informed consent. The research will analyze the impact of nasogastric tube placement on morbidity and mortality in SBO cases.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with small bowel obstruction.
Not a fit: Patients who have had abdominal surgery within the last 7 days or are unable to provide informed consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could clarify the role of nasogastric tube placement in managing small bowel obstruction, potentially improving patient care and outcomes.
How similar studies have performed: Previous retrospective studies have explored this topic, but this is one of the first prospective evaluations of nasogastric tube placement in SBO management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed small bowel obstruction * Age 18 or older Exclusion Criteria: * Abdominal surgery within 7 days * Not able to give informed consent
Where this trial is running
Göteborg and 7 other locations
- Sahlgrenska Universitetssjukhuset — Göteborg, Sweden (RECRUITING)
- Östra sjukhuset — Göteborg, Sweden (RECRUITING)
- Skånes Universitetssjukhus — Lund, Sweden (ACTIVE_NOT_RECRUITING)
- Skånes Universitetssjukhus — Malmö, Sweden (ACTIVE_NOT_RECRUITING)
- Lasarett i Motala — Motala, Sweden (RECRUITING)
- Vrinnevisjukhuset — Norrköping, Sweden (RECRUITING)
- Sundsvalls sjukhus — Sundsvall, Sweden (RECRUITING)
- Akutmottagningen US Östergötland — Linköping, Östergötland, Sweden (RECRUITING)
Study contacts
- Principal investigator: Daniel B Wilhelms, PhD — Linkoeping University
- Study coordinator: Jens Wretborn, PhD
- Email: jens.wretborn@liu.se
- Phone: +4610 103 00 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Small Bowel Obstruction, Frailty, Nasogastric Tube, Small bowel obstruction, nasogastric tube, pain, mortality, morbidity